FDA approves first new ALS drug in over 20 years

Nature Reviews Drug Discovery 16, 375 (2017). doi:10.1038/nrd.2017.109 Author: Asher Mullard The FDA approved Mitsubishi Tanabe Pharma's edaravone for amyotrophic lateral sclerosis (ALS), the first US approval for the deadly neurodegenerative disease since riluzole in 1995.ALS is a rare disease that attacks and kills the nerve cells that control voluntary muscles, affecting the ability
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: News and Analysis Source Type: research